| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |